Browsing by Author "Fintelman-Rodrigues, Natalia"
Now showing items 1-16 of 16
-
Agathisflavone, a natural biflavonoid that inhibits SARS-CoV-2 replication by targeting its proteases
Chaves, Otávio Augusto et al. | Date Issued: 2022 -
Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way
Chaves, Otávio Augusto et al. | Date Issued: 2022 -
Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way
Chaves, Otávio Augusto et al. | Date Issued: 2022 -
Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production
Fintelman-Rodrigues, Natalia et al. | Date Issued: 2020 -
Atazanavir Is a Competitive Inhibitor of SARS-CoV-2Mpro, Impairing Variants Replication In Vitro and In Vivo
Chaves, Otávio Augusto et al. | Date Issued: 2022 -
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production
Fintelman-Rodrigues, Natalia et al. | Date Issued: 2020 -
Combination of antiviral drugs inhibits SARS-CoV- 2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture
Wang, Xuanting et al. | Date Issued: 2022 -
Computational and Experimental Approaches Identify Beta-Blockers as Potential SARS-CoV‑2 Spike Inhibitors
Phul, Ana C. et al. | Date Issued: 2022 -
Genetic evidence and host immune response in persons reinfected with SARS-CoV-2, Brazil
Fintelman-Rodrigues, Natalia et al. | Date Issued: 2021 -
Human endogenous retrovirus K activation in the lower respiratory tract of severe COVID-19 patients associates with early mortality
Temerozo, Jairo Ramos et al. | Date Issued: 2021 -
Human endogenous retrovirus K in the respiratory tract is associated with COVID‑19 physiopathology
Temerozo, Jairo R. et al. | Date Issued: 2022 -
Non-permissive SARS-CoV-2 infection in human neurospheres (preprint)
Pedrosa, Carolina da Silva Gouveia et al. | Date Issued: 2021 -
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV‑2 and Potential Mechanisms
Puhl, A. C. et al. | Date Issued: 2021 -
Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts
Teixeira, Lívia et al. | Date Issued: 2022 -
Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells
Sacramento, Carolina Q. et al. | Date Issued: 2022 -
Unlike Chloroquine, mefloquine inhibits SARS-CoV-2 infection in physiologically relevant cells and does not induce viral variants
Sacramento, Carolina Q. et al. | Date Issued: 2021